Log In

Forgot Password?
Create New Account

Loading... please wait

2023 Annual Meeting | H266 - Redefining Brain Health: Advancing Brain Health Equity Through Global Data (Practice and Policy Hub)

Wednesday 04/26/23
07:45 AM - 08:45 AM EST Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Hubs (Practice and Policy)
Natalia S. Rost, MD, MPH, FAHA, FAAN, Sarah L. Lock, JD, Simona Skerjanec, Joseph Dieleman, PhD, Kate W. Gillespie, PhD, William B. Weeks, MD, PhD
Practice, Policy, and Ethics, Health Care Disparities
Brain disorders are a significant driver of illness, spending, and death globally. The associated burden is expected to grow in the years to come, creating new challenges for health systems, employers, patients, and families. Participants will be able to describe the growing magnitude of brain disorders and the role of data to help decision-makers tasked with allocating resources for funding and public health interventions; understand the Brain Health Consortium's standardized, science-based approach for quantifying the present burden, future trends, and economic impact of brain health conditions for various stakeholders; compare and contrast variation in the burden of brain disorders across countries and age groups and by sex, and gain specific insights on underlying drivers; explain the different components and perspectives associated with cost of brain disorders and the magnitude of the indirect costs associated with brain disorders; and examine potential solutions for improving brain health equity locally and globally via better policy and resource prioritization.
0.00 CME credit
Medical Knowledge
Introductory
Business of Neurology, Diversity, Equity, and Inclusion
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student, Business Administrator
Didactic
Event Timeline
07:45 AM - 08:45 AM EST Speaker Redefining Brain Health: Advancing Brain Health Equity Through Global Data
Natalia S. Rost, MD, MPH, FAHA, FAAN, Sarah L. Lock, JD, Simona Skerjanec, Joseph Dieleman, PhD, Kate W. Gillespie, PhD, William B. Weeks, MD, PhD
Faculty Disclosures
Natalia S. Rost, MD, MPH, FAHA, FAAN Dr. Rost has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for American Academy of Neurology. Dr. Rost has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke - AHA/ASA Journal. The institution of Dr. Rost has received research support from NIH. Dr. Rost has received publishing royalties from a publication relating to health care.
Sarah L. Lock, JD Mrs. Lock has received personal compensation for serving as an employee of AARP. Mrs. Lock has stock in many publically held companies but it is all a very tiny percentage of public firms.
Simona Skerjanec Simona Skerjanec has received personal compensation for serving as an employee of Roche . Simona Skerjanec has stock in Roche.
Joseph Dieleman, PhD Prof. Dieleman has nothing to disclose.
Kate W. Gillespie, PhD Dr. Gillespie has nothing to disclose.
William B. Weeks, MD, PhD Dr. Weeks has received personal compensation for serving as an employee of Microsoft. Dr. Weeks has stock in Microsoft.